Listen to the second episode of our series Uncharted Brain: Decoding Dementia via The Anthill podcast.
Rigor académico, oficio periodístico
Artículos sobre Dementia
Mostrando 81 - 100 de 394 artículos
Listen to the first episode of our series Uncharted Brain: Decoding Dementia via The Anthill podcast.
Just months after the end of the second world war, the longest running study of health over the human life course in the world began – and it’s still going.
With an increasing number of people living with dementia worldwide and in Canada, it’s crucial to find ways to promote community awareness and prevent people with dementia from getting lost.
We dug into what was behind the headlines on nose-picking and dementia so you don’t have to. Here’s what the study really says.
A podcast and long read series exploring new research into the brain and dementia.
People who live with dementia and those who care for them are at increased risk of social isolation and loneliness. That can make floods and other emergencies especially distressing and dangerous.
Up to 60% of people with dementia will get lost at some point after diagnosis.
Too much amyloid-beta in the brain has long been considered the cause of Alzheimer’s. New research suggests it might be the opposite.
Lecanemab, an experimental dementia drug, slowed cognitive decline by 27% in late-stage clinical trials.
Older people with COVID are at higher risk of a new Alzheimer’s diagnosis within a year of testing positive. Vaccination against viral infection remains one of several important preventative measures.
We asked more than 830 older Australians about their awareness of 12 factors that help reduce dementia risk.
New study finds that middle-aged people who had nightmares every week, are four times more likely to experience cognitive decline.
Action is needed to hold off a wave of dementia cases in an aging population. One of the most effective tools to reduce the prevalence of dementia is to address modifiable factors.
Alzheimer’s may not be primarily a disease of the brain. It may be a disorder of the immune system within the brain. Beta-amyloid may not be an abnormal protein, but part of the brain’s immune system.
You may dismiss many behaviour changes as just a normal part of ageing. But it may be doggy dementia, or canine cognitive dysfunction.
A highly cited paper on Alzheimer’s disease may have been purposely manipulated.
People who get COVID continue to face increased risks of developing some neurological and psychiatric conditions, like psychosis and dementia, for up to two years afterwards.
Not all Alzheimer’s research has been compromised by allegations of scientific fraud. But we should interrogate whether the governing bodies of research and drug approvals are truly effective.
The first step is to trust in the friendship and begin to explore how it can be sustained over time.
Principales colaboradores
-
Associate Professor, Turner Institute for Brain and Mental Health, Monash University
-
Associate professor, University of Sydney
-
Research Fellow in Neuroimmunology, UCL
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Associate Professor in Cellular Neuroscience, University of Reading
-
Professor in Ageing and Health, University of Sydney
-
Senior Research Fellow, University of Liverpool
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
Editor and Co-Host, The Conversation Weekly Podcast, The Conversation
-
Professor of Psychology in Epidemiology, UCL
-
Professor of Neurology, UCL
-
Professor Emeritus of Molecular Neurobiology at the University of Manchester and a Visiting Professorial Fellow, University of Oxford
-
Post grad student at University of Edinburgh, The University of Edinburgh
-
Investigations Editor, Insights, The Conversation
-
Associate Professor, Neurology, University of Florida
